Men Face More Diabetes Complications Than Women
By Lori Solomon HealthDay Reporter
FRIDAY, May 17, 2024 -- Men with diabetes have a greater risk for complications than women, irrespective of diabetes duration, according to a study published online May 16 in the Journal of Epidemiology & Community Health.
Alice A. Gibson, from the University of Sydney, and colleagues investigated sex differences in incident microvascular and macrovascular complications among adults with diabetes. The analysis included 25,713 individuals (aged 45 years and older and with diabetes) participating in the 45 and Up Study.
The researchers found that age-adjusted incidence rates were 37 per 1,000 person-years for cardiovascular disease (CVD), 52 for eye, 21 for lower limb, and 32 for kidney complications. Compared with women, men had a greater risk for CVD (adjusted hazard ratio [aHR], 1.51), lower limb (aHR, 1.47), and kidney complications (aHR, 1.55), as well as a greater risk for diabetic retinopathy (aHR, 1.14). Over 10 years, 44 percent of men experienced a CVD complication, 57 percent an eye complication, 25 percent a lower-limb complication, and 35 percent a kidney complication compared with 31, 61, 18, and 25 percent of women, respectively. There was no substantial effect of diabetes duration (<10 versus ≥10 years) on sex differences in complications.
"Given the high rates of complication in both sexes, this study highlights the importance of targeted complication screening and prevention strategies from the time of diagnosis," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted May 2024
Read this next
Semaglutide Cuts Risk for Kidney Outcomes, Death in CKD With T2DM
FRIDAY, May 31, 2024 -- For patients with type 2 diabetes and chronic kidney disease, semaglutide reduces the risk for clinically important kidney outcomes and death from...
Demographic, Clinical, Financial Factors Tied to GLP-1 Agonist Discontinuation
WEDNESDAY, May 29, 2024 -- Specific demographic, clinical, and financial characteristics are associated with glucagon-like peptide 1 (GLP-1) receptor agonist discontinuation...
Semaglutide Boosts Kidney Outcomes With Obesity + Cardiovascular Disease
TUESDAY, May 28, 2024 -- Once-weekly subcutaneous semaglutide shows a benefit for kidney outcomes in people with overweight or obesity and established cardiovascular disease...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.